Aphria (TSX:APHA)(NASDAQ:APHA) stock has sure had a spectacular comeback in 2021. In fact, Aphria’s stock price is up more than 100% so far this year. And its rise seems to have only just begun. But the cannabis industry is not only a high-growth one. It’s also a highly competitive one. This means that not all of the cannabis companies around…
Read More
Canopy Growth (TSX:WEED)(NYSE:CGC) had gotten off to an impressive start in 2021. From Jan. 1 through mid-February, shares of Canopy doubled. That’s not bad for a six-week return. However, since then, shares have traded to the downside, giving up nearly all their gains from earlier this year. Today, shareholders can pick up Canopy Growth at what many growth investors may…
Read More
Anticipation of cannabis legalization in the U.S. is driving a tremendous amount of hype around TSX-listed cannabis stocks today. That said, these cannabis stocks have seen some recent downside. Indeed, investors appear to be pricing in valuation risk with these stocks, many of which are perfectly priced. That said, some cannabis stocks are still performing quite well. Among the group…
Read More
A new “green rush” is upon us. Or, at least, cannabis investors hope so. The key driver of this rush to cannabis stocks remains legalization. This time, anticipation of U.S. legalization has set the stage for another bout of hysteria of late. Indeed, I believe that much of the hype right now in the cannabis space is unwarranted. That said,…
Read More
Green Thumb Industries (TSXV:GTII) has been under fire of late. There’s been some pretty damning allegations highlighting some serious concerns with this stock. That said, the fact this stock has been a four-bagger for investors suggests there’s a lot of momentum behind this name. Here’s what to make of these allegations. Intriguing headline-making article spurs conversation A recent article in the…
Read More
Cronos Group (TSX:CRON)(NASDAQ:CRON) is an innovative global cannabinoid (CBD) company with international production and distribution across five continents. Cronos Group builds disruptive intellectual property by advancing cannabis research, technology, and product development. The company is in the process of building an iconic brand portfolio that responsibly elevates the consumer experience. In the United States, Cronos markets and distributes solely U.S.…
Read More
The U.S. will become the world’s largest legalized cannabis market. That is, if the Biden administration moves forward with recreational cannabis legalization legislation. Indeed, on this catalyst, the jury is still out. However, speculators will do what they do best and speculate. Today, the cannabis sector is red hot. Indeed, investors in growth sectors like cannabis want companies leveraged to…
Read MoreSandusky, Ohio–(Newsfile Corp. – April 13, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company’s ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method – U.S.…
Read More
Given where valuations are in the market today, the search for great risk-adjusted returns is on. For those looking to make long-term investments, here are three top picks to consider today. WPT Industrial REIT Industrial real estate remains the top long-term real estate sub-sector I’d invite investors to consider today. Other real estate classes like office and retail could see…
Read MorePAO Group, Inc. (USOTC: PAOG) today confirmed a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Source: Kaly PAOG To Publish Latest CBD Pharmaceutical Developments Tomorrow, Tuesday April 13, 2021 Kaly
Read More